DEVICE AND METHOD FOR MONITORING OF ABSOLUTE OXYGEN SATURATION AND TISSUE HEMOGLOBIN CONCENTRATION

• US 20140107440A1
• Filed: 12/16/2013
• Published: 04/17/2014
• Est. Priority Date: 06/10/2009
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Kuhn, Jonathan L., Cinbis, Can, Carney, James K.
• Granted Patent: US 9,044,181 B2
• Time in Patent Office: Days
• US Class Current: 600/324
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/14552 Details of sensors specially adapted therefor
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/7239 using differentiation including higher order derivatives
• CPC Class Codes: A61N 1/36557 controlled by chemical substances in blood

Abstract

A method and medical device for detecting signals that detects emitted light scattered by a volume of tissue delivered along a first pathway at a plurality of wavelengths to generate corresponding first detected light intensity output signals, detects emitted light scattered by the volume of tissue delivered along a second pathway different from the first pathway at a plurality of wavelengths to generate corresponding second detected light intensity output signals, determines whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a predetermined threshold, and alters sensing by the device in response to the determining whether a difference is greater than the predetermined threshold.

Claims

1. A medical device for detecting signals, comprising:

a first optical assembly to detect emitted light scattered by a volume of tissue delivered along a first pathway to generate corresponding first detected light intensity output signals;

a second optical assembly to detect emitted light scattered by the volume of tissue delivered along a second pathway different from the first pathway to generate corresponding second detected light intensity output signals; and

a processor configured to determine whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a predetermined threshold, and to alter sensing by the device in response to the determining whether a difference is greater than the predetermined threshold.

2. The device of claim 1, further comprising a monitoring module couple to the processor and configured to determine a first oxygen saturation measurement corresponding to detected light emitted along the first pathway in response to the first detected light intensity output signals, and to determine a second oxygen saturation measurement corresponding to detected light emitted along the second pathway in response to the second detected light intensity output signals, wherein the processor is further configured to compare the first and second oxygen saturation measurement and determine whether a difference between the first and second oxygen saturation measurement is greater than the predetermined threshold.

3. The device of claim 2, wherein altering sensing by the device comprises selecting between the first pathway and the second pathway.

4. The device of claim 2, wherein the processor is further configured to determine levels of uniformity of the volume of tissue.

5. The device of claim 4, wherein the processor is further configured to determine whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is less than a first level threshold, identify the volume of tissue as having a first tissue uniformity in response the difference being less than the first level threshold, determine whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a second level threshold different from the first level threshold, and identify the volume of tissue as having a second tissue uniformity in response the difference being both less than the second level threshold and not less than the first level threshold.

6. The device of claim 5, wherein the processor is further configured to select between the first pathway and the second pathway in response to the identifying.

7. The device claim 1, wherein the monitoring module is further configured to determine an attenuation measurement for each wavelength of a plurality of wavelengths of the first pathway and the second pathway in response to the first and second detected light intensity output signals, determine a second derivative of the attenuation measurement for a first wavelength and a second wavelength of a plurality of wavelengths corresponding to the first pathway in response to only the first detected light intensity output signals, determine a second derivative of the attenuation measurement for a first wavelength and a second wavelength of a plurality of wavelengths corresponding to the second pathway in response to only the second detected light intensity output signals, determine a first oxygen saturation measurement corresponding to detected light emitted along the first pathway in response to the determined second derivative associated with the first pathway, and determine a second oxygen saturation measurement corresponding to detected light emitted along the second pathway in response to the determined second derivative associated with the second pathway, and wherein the processor is further configured to compare the first and second oxygen saturation measurement.

8. The device of claim 7, wherein the processor is further configured to determine levels of uniformity of the volume of tissue.

9. The device of claim 8, wherein the processor is further configured to determine whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is less than a first level threshold, identify the volume of tissue as having a first tissue uniformity in response the difference being less than the first level threshold, determine whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a second level threshold different from the first level threshold, and identifying the volume of tissue as having a second tissue uniformity in response the difference being both less than the second level threshold and not less than the first level threshold.

10. The device of claim 9, wherein the processor is further configured to select between the first pathway and the second pathway in response to the identifying.

11. The device of claim 1, wherein the monitoring module is further configured to determine an attenuation measurement for each wavelength of a plurality of wavelengths of the first pathway and the second pathway in response to the first and second detected light intensity output signals, determine a second derivative of the attenuation measurement for a first wavelength and a second wavelength of a plurality of wavelengths corresponding to the first pathway in response to only the first detected light intensity output signals, determine a second derivative of the attenuation measurement for a first wavelength and a second wavelength of a plurality of wavelengths corresponding to the second pathway in response to only the second detected light intensity output signals, determine a scaled second derivative of the attenuation measurement of the first wavelength for the first pathway using the determined second derivative of the attenuation of the second wavelength for the first pathway, determine a first oxygen saturation measurement corresponding to detected light emitted along the first pathway in response to the determined scaled second derivative for the first pathway, determine a scaled second derivative of the attenuation measurement of the first wavelength for the second pathway using the determined second derivative of the attenuation of the second wavelength for the second pathway, and determine a second oxygen saturation measurement corresponding to detected light emitted along the first pathway in response to the determined scaled second derivative for the second pathway, wherein the processor is further configured to compare the first and second oxygen saturation measurement.

12. A computer readable medium having computer executable instructions for performing a method comprising:

detecting emitted light scattered by a volume of tissue delivered along a first pathway at a plurality of wavelengths to generate corresponding first detected light intensity output signals;

detecting emitted light scattered by the volume of tissue delivered along a second pathway different from the first pathway at a plurality of wavelengths to generate corresponding second detected light intensity output signals;

determining whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a predetermined threshold; and

altering sensing by the device in response to the determining whether a difference is greater than the predetermined threshold.